Table 1 Characteristics of CKD patients at index date with and without COVID-19. COPD, chronic obstructive pulmonary disorder. COVID-19 critical illness included patients treated in intensive care unit and/or with invasive mechanical ventilation.

From: Long term outcomes of patients with chronic kidney disease after COVID-19 in an urban population in the Bronx

 

COVID + (n = 834)

COVID- (n = 6167)

P Value

Demographics

   

Age in years, mean (sd)

75.5 (12.1)

76.9 (11.6)

 < 0.001

Male sex, n (%)

321 (38.5%)

2160 (35.0%)

0.05

Hispanic

309 (37.1%)

1815 (29.4%)

 < 0.001

White

79 (9.5%)

650 (10.5%)

0.34

Black

353 (42.3%)

2979 (48.3%)

0.001

Other

93 (11.2%)

723 (11.7%)

0.63

Comorbidities, n (%)

   

Hypertension

801 (96.0%)

5598 (90.8%)

 < 0.001

Diabetes

557 (66.8%)

3256 (52.8%)

 < 0.001

COPD

150 (18.0%)

757 (12.3%)

 < 0.001

Asthma

236 (28.3%)

1058 (17.2%)

 < 0.001

Liver

208 (24.9%)

995 (16.1%)

 < 0.001

Smoking

245 (29.4%)

1600 (25.9%)

0.04

Heart Failure

246 (29.5%)

1034 (16.8%)

 < 0.001

Cancer

192 (23.0%)

1109 (18.0%)

 < 0.001

Obesity

318 (38.1%)

1868 (30.3%)

 < 0.001

Baseline eGFR

45.1 (9.6)

46.5 (9.2)

 < 0.001

AKI

110 (13.2%)

50 (0.8%)

 < 0.001

COVID-19 Hospitalization

533 (63.9%)

-

-

COVID-19 Critical Illness

11 (1.3%)

-

-

Back to article page